[시장보고서]동물 모델 시장 규모, 점유율, 동향 분석 보고서 : 동물 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

동물 모델 시장 규모, 점유율, 동향 분석 보고서 : 동물 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Animal Model Market Size, Share & Trends Analysis Report By Animal Type (Mice, Guinea Pigs), By Application (Cancer, Infectious Disease), By End Use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1888647

리서치사 : Grand View Research

발행일 : 2025년 11월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,747,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,217,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,157,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

동물 모델 시장 요약

세계의 동물 모델 시장 규모는 2024년에 24억 2,000만 달러로 추정되며, 2033년까지 51억 8,000만 달러에 달할 것으로 예측됩니다.

2025년부터 2033년까지 CAGR 8.94%로 성장할 것으로 예상됩니다. 생의학, 신경학, 유전학, 독성학 및 암 연구에서 동물 모델의 활용이 확대되면서 세계 시장 성장을 주도하고 있습니다.

또한, 신규 치료제 개발을 위한 바이오제약 기업들의 연구개발 활동의 활성화와 CRISPR 등 첨단 기술의 바이오메디컬 연구 분야로의 도입도 산업 확대에 기여하는 요인으로 작용하고 있습니다.

동물 모델 시장 점유율(지역별), 2024년 및 2033년
북미
- 북미의 동물 모델 시장, 2021-2033년
- 미국
- 캐나다
- 멕시코
유럽
- 유럽의 동물 모델 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 아시아태평양의 동물 모델 시장, 2021-2033년
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
라틴아메리카
- 라틴아메리카의 동물 모델 시장, 2021-2033년
- 브라질
- 아르헨티나
중동 및 아프리카
- 중동 및 아프리카(MEA) 동물 모델 시장, 2021-2033년
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

기업 분류
전략 매핑
2022년의 기업 점유율 분석
기업 개요/리스트
- Charles River Laboratories
- The Jackson Laboratory
- genOway
- Taconic Biosciences, Inc
- Janvier Labs
- BioModels, LLC.
- Crown Bioscience
- Inotiv
- BIOCYTOGEN
- Hooke Laboratories

KSM

영문 목차

영문목차

Animal Model Market Summary

The global animal model market size was estimated at USD 2.42 billion in 2024 and is projected to reach USD 5.18 billion by 2033, growing at a CAGR of 8.94% from 2025 to 2033. The increasing use of animal models in biomedical, neurological, genetic, toxicology, and cancer research is driving global market growth.

Moreover, growing R&D efforts by biopharmaceutical companies to develop novel therapeutics and the emergence of advanced technologies, such as CRISPR, in biomedical research, are other factors contributing to industry expansion.

Global Animal Model Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global animal model market based on animal type, application, end use, and region:

Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
Mice
Rat
Guinea Pigs
Rabbits
Hamsters
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Cancer
Immunological Disease
Infectious Disease
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical & Biotechnology Companies
Academic Research Institute
Contract Research Organization
Regional Outlook (Revenue, USD Million, 2021- 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- South Korea
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
  - 1.1.1.1. Animal Type Segment
  - 1.1.1.2. Application Segment
  - 1.1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
- 1.4.1. Objective 1
- 1.4.2. Objective2
- 1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
- 1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing Prevalence of Chronic and Lifestyle Diseases
  - 3.2.1.2. Preclinical Research Needs
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High cost of process
  - 3.2.2.2. Stringent rules pertaining to animal testing.
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis

Chapter 4. Animal Type Business Analysis

4.1. Animal Model Market: Animal Type Movement Analysis
4.2. Mice
- 4.2.1. Mice Market, 2021 - 2033 (USD Million)
4.3. Rat
- 4.3.1. Rat Market, 2021 - 2033 (USD Million)
4.4. Guinea Pig
- 4.4.1. Guinea Pig Market, 2021 - 2033 (USD Million)
4.5. Rabbits
- 4.5.1. Rabbits Market, 2021 - 2033 (USD Million)
4.6. Hamsters
- 4.6.1. Hamsters Market, 2021 - 2033 (USD Million)
4.7. Others
- 4.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

5.1. Animal Model Market: Application Movement Analysis
5.2. Cancer
- 5.2.1. Cancer Market, 2021 - 2033 (USD Million)
5.3. Immunological Disease
- 5.3.1. Immunological Disease Market, 2021 - 2033 (USD Million)
5.4. Infectious Disease
- 5.4.1. Infectious Disease Market, 2021 - 2033 (USD Million)
5.5. Others
- 5.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

6.1. Animal Model Market: End Use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
- 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
6.3. Academic Research Institute
- 6.3.1. Academic Research Institute Market, 2021 - 2033 (USD Million)
6.4. Contract Research Organization
- 6.4.1. Contract Research Organization Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

7.1. Animal Model Market Share By Region, 2024 & 2033
7.2. North America
- 7.2.1. North America Animal Model Market, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. Key Country Dynamics
  - 7.2.2.2. Competitive Scenario
  - 7.2.2.3. Regulatory Framework
  - 7.2.2.4. U.S. Animal Model Market, 2021 - 2033 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Key Country Dynamics
  - 7.2.3.2. Competitive Scenario
  - 7.2.3.3. Regulatory Framework
  - 7.2.3.4. Canada Animal Model Market, 2021 - 2033 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1. Key Country Dynamics
  - 7.2.4.2. Competitive Scenario
  - 7.2.4.3. Regulatory Framework
  - 7.2.4.4. Mexico Animal Model Market, 2021 - 2033 (USD Million)
7.3. Europe
- 7.3.1. Europe Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. UK Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Germany Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.4. France
  - 7.3.4.1. Key Country Dynamics
  - 7.3.4.2. Competitive Scenario
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. France Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Key Country Dynamics
  - 7.3.5.2. Competitive Scenario
  - 7.3.5.3. Regulatory Framework
  - 7.3.5.4. Italy Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Key Country Dynamics
  - 7.3.6.2. Competitive Scenario
  - 7.3.6.3. Regulatory Framework
  - 7.3.6.4. Spain Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Key Country Dynamics
  - 7.3.7.2. Competitive Scenario
  - 7.3.7.3. Regulatory Framework
  - 7.3.7.4. Denmark Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Key Country Dynamics
  - 7.3.8.2. Competitive Scenario
  - 7.3.8.3. Regulatory Framework
  - 7.3.8.4. Sweden Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Key Country Dynamics
  - 7.3.9.2. Competitive Scenario
  - 7.3.9.3. Regulatory Framework
  - 7.3.9.4. Norway Animal Model Market, 2021 - 2033 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.2. Japan
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. Japan Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.3. China
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. China Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.4. India
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. India Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.5. Australia
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. Regulatory Framework
  - 7.4.5.4. Australia Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.6. Thailand
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Regulatory Framework
  - 7.4.6.4. Thailand Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.7. South Korea
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Regulatory Framework
  - 7.4.7.4. South Korea Animal Model Market, 2021 - 2033 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Animal Model Market, 2021 - 2033 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Regulatory Framework
  - 7.5.2.4. Brazil Animal Model Market, 2021 - 2033 (USD Million)
- 7.5.3. Argentina
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Regulatory Framework
  - 7.5.3.4. Argentina Animal Model Market, 2021 - 2033 (USD Million)
7.6. MEA
- 7.6.1. MEA Animal Model Market, 2021 - 2033 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Regulatory Framework
  - 7.6.2.4. South Africa Animal Model Market, 2021 - 2033 (USD Million)
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Regulatory Framework
  - 7.6.3.4. Saudi Arabia Animal Model Market, 2021 - 2033 (USD Million)
- 7.6.4. UAE
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Competitive Scenario
  - 7.6.4.3. Regulatory Framework
  - 7.6.4.4. UAE Animal Model Market, 2021 - 2033 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Competitive Scenario
  - 7.6.5.3. Regulatory Framework
  - 7.6.5.4. Kuwait Animal Model Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
- 8.4.1. Charles River Laboratories
  - 8.4.1.1. Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. The Jackson Laboratory
  - 8.4.2.1. Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. genOway
  - 8.4.3.1. Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. Taconic Biosciences, Inc
  - 8.4.4.1. Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Janvier Labs
  - 8.4.5.1. Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. BioModels, LLC.
  - 8.4.6.1. Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. Crown Bioscience
  - 8.4.7.1. Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. Inotiv
  - 8.4.8.1. Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. BIOCYTOGEN
  - 8.4.9.1. Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. Hooke Laboratories
  - 8.4.10.1. Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

한글목차

동물 모델 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향 및 범위

제4장 동물 유형별 비즈니스 분석

제5장 용도별 비즈니스 분석

제6장 최종 용도별 비즈니스 분석

제7장 지역별 비즈니스 분석